About GSK
GSK is a company based in Plymouth (United States) founded in 2022 by Nicholas Lydon, George Demetri, and Alexis Borisy was acquired by GSK in January 2025. It operates as a Direct-to-Consumer (D2C) and Professional Services. GSK has raised $242 million across 2 funding rounds from investors including Blackstone, Merck and RA Capital. GSK offers products and services including Respiratory Treatments, Oncology Therapies, HIV Medications, and Infectious Disease Solutions. GSK operates in a competitive market with competitors including Intima Bioscience, Shgsmed.com, Draconis Pharma, Ilico Genetics and Checkmate Therapeutics, among others.
- Headquarter Plymouth, United States
- Founders Nicholas Lydon, George Demetri, Alexis Borisy
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Gsk Plc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$242 M (USD)
in 2 rounds
-
Latest Funding Round
$120 M (USD), Series B
Aug 07, 2024
-
Investors
Blackstone
& 10 more
-
Employee Count
Not available
-
Acquired by
GSK
(Jan 08, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GSK
GSK offers a comprehensive portfolio of products and services, including Respiratory Treatments, Oncology Therapies, HIV Medications, and Infectious Disease Solutions.
Solutions for respiratory conditions are developed and provided.
Cancer treatments are researched and offered for patients.
HIV therapies are created to manage the condition.
Treatments for infectious diseases are developed and distributed.
People of GSK
Unlock access to complete
Unlock access to complete
Funding Insights of GSK
GSK has successfully raised a total of $242M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $120 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in GSK
GSK has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include Blackstone, Merck and RA Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is provided to healthcare startups by Commodore Capital.
|
Locked | Locked | Locked | |
|
Diversified investment management is provided across multiple asset classes.
|
Locked | Locked | Locked | |
|
Early-stage and late-stage biotech and finance companies are funded.
|
Locked | Locked | Locked |
Investor details for GSK
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by GSK
Investment portfolio details for GSK
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - GSK
Detailed financials for GSK
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Gsk Comparisons
Peer comparison for GSK
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of GSK
GSK operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Intima Bioscience, Shgsmed.com, Draconis Pharma, Ilico Genetics and Checkmate Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for gastrointestinal cancer are developed using CRISPR gene-editing.
|
|
| Locked | Locked | Locked |
Drugs for esophageal cancer treatment are developed using photodynamic therapy.
|
|
| Locked | Locked | Locked |
Therapeutic solutions for cancer, pain, and immune diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of diagostic test for detection of gastric cancer
|
|
| Locked | Locked | Locked |
Develops innovative therapeutic technologies for cancer and neurological disorders.
|
|
| Locked | Locked | Locked |
Develops innovative technologies for anticancer therapies targeting gastrointestinal cancers.
|
Detailed competitors of GSK
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Gsk
Complete news archive for GSK
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GSK
GSK was founded in 2022.
GSK is headquartered in Plymouth, United States. It is registered at Plymouth, Massachusetts, United States.
GSK is a funded company, having raised a total of $242M across 2 funding rounds to date.
GSK, a leading biopharmaceutical company, is focused on uniting science, technology, and talent to address diseases. Operations are centered in therapeutic areas such as respiratory, immunology, oncology, HIV, and infectious diseases. Solutions are developed to improve global health access, particularly in lower-income regions. Commitment is shown towards environmental sustainability and ethical standards. Research and development efforts are prioritized to innovate treatments and positively impact 2.5 billion people by the decades end.
GSK's top competitors include Draconis Pharma, Ilico Genetics and Intima Bioscience.
GSK offers Respiratory Treatments, Oncology Therapies, HIV Medications, and Infectious Disease Solutions.
GSK has 11 investors. Key investors include Blackstone, Merck, RA Capital, GSK, and Commodore Capital.